This contract award, with a ceiling value of $7,679.34, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Kadcyla 100 mg vials, a branded oncology medication.
The contract is a firm fixed-price delivery order under a larger indefinite delivery contract (IDC) vehicle, valued at up to $499,999,999, that DMS Pharmaceutical Group holds with the DLA. This single-award IDC, under the SPE2DB program, allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The current delivery order for Kadcyla is not associated with a set-aside designation.
Through this contract and its broader IDC with the DLA, DMS Pharmaceutical Group provides a wide array of pharmaceutical products, including both common and specialized medications, to support the diverse medical requirements of military personnel and their dependents across various Department of Defense (DoD) healthcare facilities.
Generated 7/25/24, 9:59 AM